Clarus Therapeutics Holdings Inc

OTCPK:CRXTQ (USA)  
(Delisted) $ 0.00 0 (0%) 09:42 AM EST
At Loss
Market Cap:
$ 73.00K
Enterprise V:
$ 21.41M
Volume:
-
Avg Vol (2M):
-
Volume:
-
At Loss
Avg Vol (2M):
-

Business Description

Description
Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company is focused on focused on the commercialization of JATENZO (testosterone undecanoate), the first and only oral testosterone replacement, or testosterone replacement therapy, and JATENZO is the sole source of company's revenue.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -97.84
12-1 Month Momentum % -99.86

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -334.94

GF Value Rank

Name Current Vs Industry Vs History
EV-to-Forward-Revenue 0.71

Financials

CRXTQ's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:CRXTQ

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Clarus Therapeutics Holdings Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 16.909
EPS (TTM) ($) -1.3
Beta 0
Volatility % 159.56
14-Day RSI 0
14-Day ATR ($) 0.000021
20-Day SMA ($) 0
12-1 Month Momentum % -99.86
52-Week Range ($) 0.001 - 3.94
Shares Outstanding (Mil) 52.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Clarus Therapeutics Holdings Inc Filings

Filing Date Document Date Form
No Filing Data

Clarus Therapeutics Holdings Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Clarus Therapeutics Holdings Inc Frequently Asked Questions

What is Clarus Therapeutics Holdings Inc(CRXTQ)'s stock price today?
The current price of CRXTQ is $0.00. The 52 week high of CRXTQ is $3.94 and 52 week low is $0.00.
When is next earnings date of Clarus Therapeutics Holdings Inc(CRXTQ)?
The next earnings date of Clarus Therapeutics Holdings Inc(CRXTQ) is .
Does Clarus Therapeutics Holdings Inc(CRXTQ) pay dividends? If so, how much?
Clarus Therapeutics Holdings Inc(CRXTQ) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1